Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells.

Zhou R, Huang W, Yao Y, Wang Y, Li Z, Shao B, Zhong J, Tang M, Liang S, Zhao X, Tong A, Yang J.

Int J Oncol. 2013 Aug;43(2):611-21. doi: 10.3892/ijo.2013.1972.

PMID:
23727877
2.

Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.

Ma YL, Peng JY, Zhang P, Huang L, Liu WJ, Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX, Qin HL.

J Proteome Res. 2009 Oct;8(10):4525-35. doi: 10.1021/pr900365e.

PMID:
19715280
3.

A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.

Peng J, Zhang Q, Ma Y, Wang Y, Huang L, Zhang P, Chen J, Qin H.

Electrophoresis. 2009 Sep;30(17):2976-87. doi: 10.1002/elps.200900203.

PMID:
19711377
4.

Tumor suppressor functions of miR-133a in colorectal cancer.

Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J.

Mol Cancer Res. 2013 Sep;11(9):1051-60. doi: 10.1158/1541-7786.MCR-13-0061.

5.

Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes.

Zou J, Luo H, Zeng Q, Dong Z, Wu D, Liu L.

J Transl Med. 2011 Jun 25;9:97. doi: 10.1186/1479-5876-9-97.

6.

The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.

Yang IP, Tsai HL, Huang CW, Huang MY, Hou MF, Juo SH, Wang JY.

PLoS One. 2013 Jun 28;8(6):e66842. doi: 10.1371/journal.pone.0066842.

7.

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.

Li X, Wang J, Zhang X, Zeng Y, Liang L, Ding Y.

Ann Surg Oncol. 2012 Jan;19(1):145-53. doi: 10.1245/s10434-011-1944-4.

PMID:
21861235
8.

Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.

Kanojia D, Garg M, Gupta S, Gupta A, Suri A.

Am J Pathol. 2011 Mar;178(3):1009-20. doi: 10.1016/j.ajpath.2010.11.047.

9.

Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.

Zeng ZL, Luo HY, Yang J, Wu WJ, Chen DL, Huang P, Xu RH.

Clin Cancer Res. 2014 Feb 15;20(4):1042-52. doi: 10.1158/1078-0432.CCR-13-0171.

10.

p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.

Yuan XS, Zhang Y, Guan XY, Dong B, Zhao M, Mao LL, Lu YY, Tian XY, Hao CY.

J Cancer Res Clin Oncol. 2013 Jul;139(7):1211-20. doi: 10.1007/s00432-013-1434-0.

PMID:
23576022
11.
12.

microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.

Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.

Oncogene. 2013 Oct 17;32(42):5078-88. doi: 10.1038/onc.2012.526.

PMID:
23208495
13.

Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.

Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H.

Mol Cell Proteomics. 2009 Aug;8(8):1878-90. doi: 10.1074/mcp.M800541-MCP200.

14.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H.

J Proteome Res. 2007 Jul;6(7):2495-501.

PMID:
17542627
15.

Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.

Zhao L, Liu L, Wang S, Zhang YF, Yu L, Ding YQ.

J Cancer Res Clin Oncol. 2007 Oct;133(10):771-82.

PMID:
17503081
16.

Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.

Liu YS, Hsu HC, Tseng KC, Chen HC, Chen SJ.

Biomed Pharmacother. 2013 Oct;67(8):791-9. doi: 10.1016/j.biopha.2013.08.001.

PMID:
24138824
17.

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.

Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y, Qin HL.

Ann Surg Oncol. 2012 Aug;19(8):2753-62. doi: 10.1245/s10434-011-2194-1.

PMID:
22219067
18.

High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.

Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, Al-Kuraya KS.

Am J Gastroenterol. 2009 Jul;104(7):1790-801. doi: 10.1038/ajg.2009.230.

PMID:
19491830
19.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

20.

An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.

Han CL, Chen JS, Chan EC, Wu CP, Yu KH, Chen KT, Tsou CC, Tsai CF, Chien CW, Kuo YB, Lin PY, Yu JS, Hsueh C, Chen MC, Chan CC, Chang YS, Chen YJ.

Mol Cell Proteomics. 2011 Apr;10(4):M110.003087. doi: 10.1074/mcp.M110.003087.

Supplemental Content

Support Center